Home >Technologies Available >Technologies available for licensing

Method for indicating the presence of neurodegenerative diseases using clinical biomarkers

Image from Licence Details: Method for indicating the presence of neurodegenerative diseases using clinical biomarkers

Applications: Glycosphingolipid  (GSL) biomarkers for Parkinson’s disease

A method of comparing ganglioside fingerprints from a patient sample, to diagnose disease or disorders such as Parkinson’s (PD) or Dementia. The invention also relates to classifying a subject into subgroups and so can be used stratifying patients for trials.

Features Benefits
  • Parkinson’s plasma diagnostic.
  • Plasma changes in GSLs characteristic of PD can be identified and quantified.
  • Diagnostic test.
  • Could be used for determining risk, prognosis and stratification of patients for clinical trials of disease modifying therapies.
  • Glycosphingolipid fingerprint.
  • Change in GSL fingerprint  characteristic of PD in multiple cohorts including prodromal patients to determine risk of progression to PD.

Patented & available for:

  • Licensing
  • Co-development
  • Consulting
Request more information
about this technology

Back to Technologies Available

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation